Breaking: Evelo Biosciences and Bio-Rad Agree on Sublease Termination and Surrender Deal
- July 20th, 2023
- 370 views
According to a regulatory filing with the SEC, Evelo Biosciences, Inc. (Nasdaq: EVLO) has entered into a Sublease Termination and Surrender Agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO). The agreement terminates the Sublease, which provided Evelo Biosciences with approximately 40,765 square feet of office and laboratory space in Cambridge, Massachusetts. The termination will become effective on September 15, 2023.
As part of the agreement, Evelo Biosciences will pay Bio-Rad a one-time termination payment of $523,556. Additionally, Bio-Rad is entitled to draw on a letter of credit for $850,000 and retain the proceeds. Further, there may be an additional payment of up to $2,500,000 if Evelo Biosciences completes a Monetization Event.
In after-hours, $EVLO is currently trading at $11.24 (+14.00%), and $BIO is at $400.00 (+0.45%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
NJCP National Football Conference Names David Dalton Head Coach of Salt Lake Yeti
February 06th, 2026FDA Takes New Approach to "No Artificial Colors" Claims
February 06th, 2026NJCP National Football Conference Announces Micah Deckart as Head Coach of the Idaho Outlaws
February 05th, 2026
Member Login